Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated by candidiasis

Cutis

Volumn 77, Issue 2, 2006, Pages 113-120

  Spraker, Mary K ^a   Gisoldi, Elvira M ^b   Siegfried, Elaine C ^c   Fling, John A ^d   De Espinosa, Zila D ^e   Quiring, John N ^b,f   Zangrilli, Stephanie G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Barrier Therapeutics   (United States)

^c Kids Dermatology   (United States)

^d University of North Texas Health Science Center   (United States)

^e Clinical Metropolis II ^*  (Panama)

^f QST Consultations Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DERMATOLOGICAL AGENT; DRUG VEHICLE; MICONAZOLE; PETROLATUM; ZINC OXIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPER DERMATITIS; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MALE; MUCOCUTANEOUS CANDIDIASIS; MULTICENTER STUDY; NEWBORN; OINTMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VEHICLES;

ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; CANDIDIASIS, CUTANEOUS; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; DIAPER RASH; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICONAZOLE; OINTMENTS; PETROLATUM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VEHICLES; ZINC OXIDE;

EID: 33645100086     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ward DB, Fleischer AB Jr, Feldman SR, et al. Characterization of diaper dermatitis in the United States. Arch Pediatr Adolesc Med. 2000;154:943-946.
2. Atherton DJ. A review of the pathophysiology, prevention and treatment of irritant diaper dermatitis. Curr Med Res Opin. 2004;20:645-649.
3. Dixon PN, Warin RP, English MP. Role of Candida albicans infection in napkin rashes. BMJ. 1969;2:23-27.
4. Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol. 1994;31(3 pt 2):S2-S5.
5. Fleischer AB, Feldman SR. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians. Clin Ther. 1999;21:1725-1731.
6. Lotrisone Cream, Lotrisone Lotion [package insert]. Kenilworth, NJ: Schering Corporation; 2004.
7. Concannon P, Gisoldi E, Phillips S, et al. Diaper dermatitis: a therapeutic dilemma, results of a double-blind placebo controlled trial of miconazole nitrate 0.25%. Pediatr Dermatol. 2001;18:149-155.
8. Gallup E, Plott T, and Ciclopirox TS Investigators. A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans. J Drugs Dermatol 2005;4:29-34.
9. Arad A, Mimouni D, Ben-Amitai D, et al. Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis. Dermatology. 1999;199:319-322.
10. Akin F, Spraker M, Aly R, et al. Effects of breathable disposable diapers: reduced prevalence of Candida and common diaper dermatitis. Pediatr Dermatol. 2001;18:282-290.
11. Sires UI, Mallory SB. Diaper dermatitis. Postgrad Med. 1995;98:79-84.
12. Janniger CK, Thomas I. Diaper dermatitis: an approach to prevention employing effective diaper care. Cutis. 1993;52:153-155.
13. Leyden JJ, Kligman AM. The role of microorganisms in diaper dermatitis. Arch Dermatol. 1978;114:56-59.
14. Darwazeh AM, al-Bashir A. Oral candidal flora in healthy infants. J Oral Pathol Med. 1995;24:361-364.
15. Gokalp AS, Aldirmaz C, Oguz A, et al. Relation between the intestinal flora and diaper dermatitis in infancy. Trop Geogr Med. 1990;42:238-240.
16. Rebora A, Leyden JJ. Napkin (diaper) dermatitis and gastrointestinal carriage of Candida albicans. Br J Dermatol. 1981;105:551-555.
17. Jordan WE, Lawson KD, Berg RW, et al. Diaper dermatitis: frequency and severity among a general infant population. Pediatr Dermatol. 1986;3:198-207.
18. Dixon PN, Warin RP, English MP. Alimentary Candida albicans and napkin rashes. BMJ. 1972;86:458-462.
19. Traore O, Springthorpe VS, Sattar SA. A quantitative study of the survival of two species of Candida on porous and non-porous environmental surfaces and hands. J Appl Microbiol. 2002;92:549-555.
20. Haffejee AA, Moodley J, Pillay K, et al. Evaluation of a new hydrocolloid occlusive dressing for central catheters used in total parenteral nutrition. S Afr J Surg. 1991;29:142-146.
21. Chiou YB, Blume-Peytavi U. Stratum corneum maturation, a review of neonatal skin function. Skin Pharmacol Physiol. 2004;17:57-66.
22. Gioulekas E, Goutzioulis M, Farmakis C, et al. Effects of macrophage colony-stimulating factor on antifungal activity of neonatal monocytes against Candida albicans. Biol Neonate. 2001;80:251-256.
23. Randolph S. When Candida turns deadly. RN. 2002;65:41-44.
24. Passeron T, Desruelles F, Gari-Toussaint M, et al. Invasive fungal dermatitis in a 770 gram neonate. Pediatr Dermatol. 2004;21:260-261.
25. Bowen JL, Tate JM, Nordoff N, et al. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol. 1999;37:3735-3737.
26. Andersen PH, Bucher AP, Saeed I, et al. Faecal enzymes: in vivo human skin irritation. Contact Dermatitis. 1994;30:152-158.
27. Yamazumi T, Kuroda T, Ohata T, et al. Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method [in Japanese]. Kansenshogaku Zasshi. 1998;72:813-819.
28. Data on file. Princeton, NJ: Barrier Therapeutics, Inc; November 24, 2004.